Drugs / 2MD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01969656 | ? → Jun 2004 | postmenopausal osteoporosis | Deltanoid Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2MD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01969656 ↗ |
| Route | Oral | “when administered orally once daily for 28 days” NCT01969656 ↗ |